PatientPlus articles are written by UK doctors and are based on research evidence, UK and European Guidelines. They are designed for health professionals to use, so you may find the language more technical than the condition leaflets.
Synonyms: naevus sebaceous, naevus sebaceous of Jadassohn, verrucous epidermal naevus, organoid naevus. Note the American spelling 'nevus'.
A sebaceous naevus is a congenital skin lesion which usually manifests as a bald patch on the scalp of the baby. The area of hair loss looks orange or yellowish, with a velvety feel and appearance. It is usually oval or circular. In adolescence, under the influence of sex hormones, it becomes bumpy and warty, with an unpleasant verrucoid appearance.
Throughout teenage years and early adulthood they usually stay quiescent. Sometimes they enlarge in later adulthood and, rarely, undergo neoplastic change which on the whole involves benign tumours.
Sebaceous naevi are hamartomas, meaning they arise from tissues normally found at that site but they grow in a disorganised way. They have a common embryological origin of the pilosebaceous-apocrine unit and therefore contain sebaceous glands, hair follicles and sweat glands. Hence the term sebaceous naevus is a little inaccurate: some pathologists prefer the term verrucous epidermal naevus or organoid naevus. Although they contain elements of hair follicles, normal terminal hair follicles are absent making the area look hairless. Most are solitary, with the scalp being the most common site.
Image from the Dermatology Atlas
Estimated prevalence is 0.3% of all newborns worldwide, with an equal sex distribution.
- Add notes to any clinical page and create a reflective diary
- Automatically track and log every page you have viewed
- Print and export a summary to use in your appraisal
- Usually, a single hairless patch (round or linear) is noted on the scalp at birth, or shortly thereafter.
- The classical velvety tan or yellow-orange appearance may be noted.
- The lesion may appear more prominent in newborns, due to the effects of maternal sex hormones.
- In adolescents the lesion tends to take on its nodular verrucoid appearance due to the influence of sex hormones.
- In later life there may be overgrowth of components of the lesion indicating possible benign or malignant tumours developing within the lesion.
The appearance of sebaceous naevi is fairly characteristic but the following lesions may have a similar appearance or affect similar areas of the body:
- Aplasia cutis congenita
- Naevus syringocystadenomatosus papilliferous
- Juvenile xanthogranulomata
- Solitary mastocytoma
- Other causes of alopecia
Biopsy may be considered for diagnostic purposes or to investigate the nature of tumours that arise within them.
About a third of people with a sebaceous naevus have systemic abnormalities affecting the brain, eye or skeletal systems. When these occur it is termed sebaceous naevus syndrome. In these cases the naevi follow the lines of Blaschko; the more extensive the cutaneous involvement, the greater the risk of extracutaneous manifestations. Subsequent problems can include infantile epilepsy, developmental delay and intellectual disability.
- Due to the difficulty of quantifying the risk of malignant transformation, some specialists advocate full-thickness skin excision before adolescence. Others recommend watchful waiting.
- Some cases will in any case not be suitable for excision due to their size and location. These should be subjected to regular review.
- Photodynamic therapy can play a role in removing the lesion.
- Seek the advice of a dermatologist and/or plastic surgeon to help decide on the need for, and timing of, excision.
- Any lesion that changes its appearance significantly, ulcerates, becomes painful, bleeds or shows other signs of potential malignancy, should be referred to a dermatologist.
- Poor cosmetic appearance.
- Development of a benign or malignant tumour within the lesion.
- Complications associated with removal of the lesion.
Of these 15%, 80% develop foci of benign neoplasms such as trichoblastomas and syringocystadenomas. The remaining 20% develop malignant changes, with basal cell carcinomas making up half of those, squamous cell carcinomas a quarter.
Usually any malignant change occurs in adulthood but it has been reported in children as young as 8 years. Malignancy can be diagnosed in the same way as other malignant skin tumours, with dermoscopy playing its usual role.
Further reading & references
- Sebaceous naevus; DermNet NZ
- Simi CM, Rajalakshmi T, Correa M; Clinicopathologic analysis of 21 cases of nevus sebaceus: a retrospective study. Indian J Dermatol Venereol Leprol. 2008 Nov-Dec;74(6):625-7.
- Moody MN, Landau JM, Goldberg LH; Nevus sebaceous revisited. Pediatr Dermatol. 2012 Jan-Feb;29(1):15-23. doi: 10.1111/j.1525-1470.2011.01562.x. Epub 2011 Oct 13.
- Laura FS; Epidermal nevus syndrome. Handb Clin Neurol. 2013;111:349-68. doi: 10.1016/B978-0-444-52891-9.00041-5.
- Asch S, Sugarman JL; Epidermal nevus syndromes. Handb Clin Neurol. 2015;132:291-316. doi: 10.1016/B978-0-444-62702-5.00022-6.
- Sebaceous naevus; DermNet NZ
- Rosen H, Schmidt B, Lam HP, et al; Management of nevus sebaceous and the risk of Basal cell carcinoma: an 18-year review. Pediatr Dermatol. 2009 Nov-Dec;26(6):676-81. doi: 10.1111/j.1525-1470.2009.00939.x. Epub 2009 Jul 20.
- Nevus sebaceus of Jadassohn; OnlineDermClinic
- Babilas P, Szeimies RM; The use of photodynamic therapy in dermatology. G Ital Dermatol Venereol. 2010 Oct;145(5):613-30.
- Idriss MH, Elston DM; Secondary neoplasms associated with nevus sebaceus of Jadassohn: a study of 707 cases. J Am Acad Dermatol. 2014 Feb;70(2):332-7. doi: 10.1016/j.jaad.2013.10.004. Epub 2013 Nov 20.
- Cribier B, Scrivener Y, Grosshans E; Tumors arising in nevus sebaceus: A study of 596 cases. J Am Acad Dermatol. 2000 Feb;42(2 Pt 1):263-8.
- Enei ML, Paschoal FM, Valdes G, et al; Basal cell carcinoma appearing in a facial nevus sebaceous of Jadassohn: dermoscopic features. An Bras Dermatol. 2012 Jul-Aug;87(4):640-2.
Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. EMIS has used all reasonable care in compiling the information but makes no warranty as to its accuracy. Consult a doctor or other healthcare professional for diagnosis and treatment of medical conditions. For details see our conditions.
Dr Sean Kavanagh
Dr Oliver Starr
Dr Adrian Bonsall